Thymic stroma-derived T cell growth factor (TSTGF). IV. Capacity of TSTGF to promote the growth of L3T4- Lyt-2- thymocytes by synergy with phorbol myristate acetate or various IL

J Immunol. 1989 Feb 15;142(4):1195-202.

Abstract

The present study investigates the role of thymic stroma-derived T cell growth factor (TSTGF) in promoting the growth of L3T4- Lyt2- (double-negative) thymocytes. Partially purified TSTGF samples were prepared from the culture supernatant of a newly established thymic stromal cell line, MRL104.8a. The TSTGF alone induced only marginal proliferation of double-negative thymocytes, whereas this factor exerted a potent growth-promoting effect on these cells in combination with PMA. Because such an enhanced proliferation was not inhibited by anti-IL-4 or anti-IL-2R antibody, this was not due to the stimulation of an autocrine mechanism involving the production and utilization of IL-4 or IL-2. In scrutinizing PMA-equivalent physiologic substance(s), IL-1 was revealed to be capable of replacing the role of PMA in the above co-stimulation cultures and including enhanced proliferation of double-negative thymocytes in combination with TSTGF. Although TSTGF plus IL-2 or IL-4 also exhibited an appreciable or moderate synergistic effect on the growth of double-negative thymocytes, its magnitude was weaker compared with that obtained by TSTGF plus IL-1. More important, the strikingly enhanced proliferation was induced in the combinations of TSTGF, IL-1, and IL-2 or IL-4 under conditions in which the proliferation induced by IL-1 plus IL-4 or IL-1 plus IL-2 was marginal or slight. Furthermore, such strongly enhanced proliferation was also observed in the double-negative thymocyte population which was additionally depleted of T3+ cells (namely, the L3T4- Lyt-2- T3- or dull population). These results indicate the crucial role of TSTGF in the proliferation of immature thymocytes by synergy with various cytokines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Adjuvants, Immunologic / physiology
  • Aging
  • Animals
  • Antigens, Differentiation, T-Lymphocyte*
  • Cell Division / drug effects
  • Drug Combinations
  • Drug Synergism
  • Extracellular Matrix / physiology*
  • Interleukin-2 / physiology*
  • Interleukins / pharmacology*
  • Lymphocyte Activation / drug effects
  • Mice
  • Mice, Inbred C3H
  • T-Lymphocytes / classification
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / physiology
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Thymus Gland / physiology*

Substances

  • Adjuvants, Immunologic
  • Antigens, Differentiation, T-Lymphocyte
  • Drug Combinations
  • Interleukin-2
  • Interleukins
  • Tetradecanoylphorbol Acetate